Mark Lee Barr, MD

Associate Professor of Surgery

Chair for the Department's Appointments, Promotion and Tenure Committee

Director of Cardiac Surgery Clearkship

Image of Mark Lee Barr, MD
Is this your profile? Click to edit

Overview

Dr. Mark L. Barr obtained his medical degree from Mount Sinai School of Medicine and completed 10 years of postgraduate residency at New York University and Columbia University, including a 2-year NIH-sponsored research fellowship in transplantation immunology. He is a tenured faculty member in the Department of Surgery and serves as Co-Director of the USC Transplantation Institute; Chair of the Department of Surgery Appointments, Promotions, and Tenure Committee; and Director of the Cardiothoracic Surgery Medical Student Clerkship. He has served as Chair of the UNOS Thoracic Transplantation Committee, as President of the International Society for Heart and Lung Transplantation (ISHLT), as Chair of the Thoracic Committee of the American Society of Transplant Surgeons (ASTS), and on the Board of Directors of the ISHLT, the ASTS, the American Society of Transplantation, and the Board of Directors of the OPTN / UNOS. Dr. Barr was the Chair of the Advisory Committee on Transplantation (ACOT) under the auspices of the Secretary of the Department of Health and Human Services during the 8 years of the Obama administration. He is an author / co-author on more than 150 peer-reviewed publications and book chapters in the fields of cardiothoracic surgery and heart and lung transplantation, has served on multiple scientific review boards for NIAID, NHLBI, and NCRR of the National Institutes of Health, and was a Deputy Editor of the American Journal of Transplantation for 15 years.

Publications

  • Surrogate markers and risk factors for chronic lung allograft dysfunction. Am J Transplant. 2004 Jul; 4(7):1171-8.. View in PubMed
  • Neochordal repair of the posterior mitral leaflet. J Thorac Cardiovasc Surg. 2004 Feb; 127(2):440-7.. View in PubMed
  • A decade of living lobar lung transplantation: recipient outcomes. J Thorac Cardiovasc Surg. 2004 Jan; 127(1):114-22.. View in PubMed
  • Potential role for antiangiogenic proteins in the myocardial infarction repair process. J Surg Res. 2004 Jan; 116(1):156-64.. View in PubMed
  • Thoracic organ transplantation. Am J Transplant. 2004; 4.. View in PubMed
  • Determinants of quality of life changes among long-term cardiac transplant survivors: results from longitudinal data. J Heart Lung Transplant. 2003 Oct; 22(10):1157-67.. View in PubMed
  • Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection. Transplantation. 2003 Aug 15; 76(3):609-14.. View in PubMed
  • Living lobar transplantation. Chest Surg Clin N Am. 2003 Aug; 13(3):505-24.. View in PubMed
  • Depopulated vena caval homograft: a new venous conduit. J Thorac Cardiovasc Surg. 2003 Aug; 126(2):498-503.. View in PubMed
  • Photopheresis for the prevention and treatment of transplant rejection. J Cutan Med Surg. 2003 Jul-Aug; 7(4 Suppl):18-9.. View in PubMed